SoCalBio

The trade association of the bioscience industries in Greater Los Angeles and neighboring communities

Community News

Community News

  • Researchers Awarded 2019 Canon Medical Systems USA, Inc./RSNA Research Grants
    on October 22, 2019 at 1:00 pm

    TUSTIN, Calif.--(BUSINESS WIRE)--The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation awarded its 2019 Canon Medical Systems USA, Inc./RSNA Research Seed Grant to Eric James Hohenwalter, M.D., and the 2019 Canon Medical Systems USA, Inc./RSNA Research Resident Grants to Arash Nazeri, M.D. and Aaron Benjamin Simon, M.D., Ph.D. These grants are made possible by Canon Medical Systems USA, Inc.’s support of the RSNA R&E Foundation. The Canon […]

  • GTX medical BV and NeuroRecovery Technologies Inc. Merge to Create Leading Neurostimulation Company for Spinal Cord Injury
    on October 22, 2019 at 9:00 am

    EINDHOVEN, Netherlands & LAUSANNE, Switzerland & LOS ANGELES--(BUSINESS WIRE)--GTX medical BV (‘GTX’, formerly known as G-Therapeutics) and NeuroRecovery Technologies Inc. (‘NRT’) today announced their merger to create a leading global company committed to developing novel neuromodulation therapies to improve functional recovery of people with Spinal Cord Injuries (SCI). The merged entity will be known as GTX medical BV. The Christopher & Dana Reeve […]

  • Canon Medical’s Ultra-High Resolution CT Receives FDA Clearance for Artificial Intelligence-Based Image Reconstruction Technology
    on October 21, 2019 at 1:00 pm

    TUSTIN, Calif.--(BUSINESS WIRE)--Canon Medical Systems USA, Inc. has received 510(k) clearance on its Advanced Intelligent Clear-IQ Engine (AiCE) for the Aquilion PrecisionTM further expanding access to its new deep convolutional neural network (DCNN) image reconstruction technology. This technology, now available on both the Aquilion Precision and Aquilion ONE / GENESIS EditionTM premium CT systems, uses a deep learning algorithm to differentiate signal from noise so that it can suppress noise

  • Urovant Sciences Initiates Part 2 of Phase 3 COURAGE Study of Vibegron for Overactive Bladder in Men with Benign Prostatic Hyperplasia
    on October 21, 2019 at 12:00 pm

    IRVINE, Calif. & BASEL, Switzerland--(BUSINESS WIRE)--Urovant Sciences Initiates Part 2 of Phase 3 COURAGE Study of Vibegron for Overactive Bladder in Men with Benign Prostatic Hyperplasia

  • Arrowhead Pharmaceuticals Hosts R&D Day on Emerging Pipeline of RNAi Therapeutics
    on October 18, 2019 at 11:30 am

    PASADENA, Calif.--(BUSINESS WIRE)---- $arwr--Arrowhead Pharmaceuticals is hosting a Research & Development (R&D) Day today in New York to discuss its emerging pipeline of RNAi therapeutics

  • Simulations Plus Partners with Large Pharmaceutical Company to Develop the Virtual Bioequivalence Trial Simulator™ Module
    on October 17, 2019 at 12:30 pm

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced a new funded collaboration to develop the Virtual Bioequivalence Trial Simulator module in its flagship GastroPlus.

  • Compulink Showcases AI-Powered, All-in-One Orthopaedic EHR Solution at ASES 2019
    on October 16, 2019 at 5:58 pm

    NEWBURY PARK, Calif.--(BUSINESS WIRE)--Compulink showcases AI-powered, all-in-one orthopaedic EHR solution at ASES 2019.

  • Masimo to Report Third Quarter 2019 Financial Results after Market Close on Wednesday, October 30
    on October 16, 2019 at 1:00 pm

    IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today that it will release third quarter 2019 financial results for the period ended September 28, 2019, after the market closes on Wednesday, October 30, 2019. The conference call to review the results will begin at 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by Joe Kiani, Chairman and Chief Executive Officer, and Micah Young, Executive Vice President and Chief Financial Officer. A live webcast of the conference call will be a

  • Gemelli Biotech, Innovator in Microbiome Space, Producer of ibs-smart™, Announces Scientific Advisory Board
    on October 15, 2019 at 4:37 pm

    LOS ANGELES & RALEIGH, N.C.--(BUSINESS WIRE)-- #biotech--Gemelli Biotech announced the formalization of a Scientific Advisory Board to support the company’s expansion into new markets and offerings.

  • Manatt Health Releases 50-State Survey on 340B in State Medicaid Programs
    on October 15, 2019 at 1:00 pm

    LOS ANGELES--(BUSINESS WIRE)--Manatt, Phelps & Phillips, LLP, a multidisciplinary, integrated professional services firm, announced today the release of its Comprehensive 50-State Survey: State Medicaid Programs and 340B. Conducted by Manatt Health, the firm’s healthcare legal and consulting group, the report summarizes laws, regulations and sub-regulatory guidance that govern how Medicaid programs in all 50 states reimburse for both 340B and non-340B drugs, and how Medicaid programs […]

  • Axonics® Provides Update on U.S. Launch Activities
    on October 15, 2019 at 10:00 am

    IRVINE, Calif.--(BUSINESS WIRE)--Axonics Modulation Technologies, Inc. (NASDAQ: AXNX), a medical technology company that has developed and is commercializing novel implantable Sacral Neuromodulation (“SNM”) devices, today provided an update on the status of U.S. launch activities following Food & Drug Administration (“FDA”) approval of the Axonics r-SNM® System for bowel dysfunction in September 2019. On Saturday, October 12, in Orlando, Fla., Axonics completed […]

  • Simulations Plus Announces Quarterly Cash Dividend of $0.06 per Share
    on October 14, 2019 at 6:30 pm

    LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus announced today that its Board of Directors has declared a cash dividend of $0.06 per share to be distributed on Nov. 1, 2019.

  • PharmaCyte Biotech Successfully Completes Manufacturing of Clinical Trial Product
    on October 14, 2019 at 1:00 pm

    LAGUNA HILLS, Calif.--(BUSINESS WIRE)-- #INDstatus--PharmaCyte Biotech completes successfully the manufacturing of its clinical trial product for locally advanced, inoperable pancreatic cancer.

  • Nonprofit CureDuchenne Launches Biobank to Fuel Research for Duchenne Muscular Dystrophy
    on October 12, 2019 at 5:00 pm

    NEWPORT BEACH, Calif.--(BUSINESS WIRE)-- #biobank--Nonprofit CureDuchenne launches biobank to fuel research for Duchenne muscular dystrophy. UCI and RUCDR Infinite Biologics to partner on resource.

  • MedTech Innovator Names NDR Medical as 2019 Asia Pacific Competition Winner at The MedTech Forum
    on October 11, 2019 at 1:00 am

    SINGAPORE & LOS ANGELES--(BUSINESS WIRE)--MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, today announced NDR Medical as the winner of its 2019 Asia Pacific Showcase Program. The winning company was determined by a live audience vote on October 9 at The Asia Pacific MedTech Forum, hosted by the Asia Pacific Medical Technology Association (APACMed), in Singapore. Based in Singapore, NDR Medical is developing a robotics system that uses […]

  • City of Hope Helps Found Biotechnology Hub for Los Angeles County’s Life Sciences Industry
    on October 10, 2019 at 4:34 pm

    DUARTE, Calif.--(BUSINESS WIRE)-- #CityofHope--Harlan Levine, M.D., president of strategy and business ventures at City of Hope, is a founding sponsor of BioLA and on its governing board.

  • NextGen Healthcare, Inc. to Host Fiscal 2020 Second Quarter Conference Call
    on October 10, 2019 at 2:00 pm

    IRVINE, Calif.--(BUSINESS WIRE)--NextGen Healthcare, Inc. (NASDAQ: NXGN), a leading provider of ambulatory-focused technology solutions, will release its fiscal 2020 second quarter ended September 30, 2019 operating results on Wednesday, October 23, 2019 after market close, with a conference call to follow at 5:00 p.m. Eastern Time. Shareholders and interested participants may listen to a live broadcast of the conference call by dialing 866-750-8947 or 720-405-1352 for international callers, an

  • OSI Systems Announces First Quarter Conference Call
    on October 10, 2019 at 12:30 pm

    HAWTHORNE, Calif.--(BUSINESS WIRE)--OSI Systems, Inc. (Nasdaq: OSIS) today announced that it will hold its quarterly conference call on Thursday, October 24, 2019 at 1:30pm PT to discuss its results for the quarter ended September 30, 2019. This call is being webcast through West Digital Solutions and the investor relations section at www.osi-systems.com. A replay of the conference call will be available from 3:00pm PT on October 24, 2019 until November 7, 2019. The replay may be accessed by vi

  • Glaukos Achieves Pipeline Milestone with Completion of Patient Enrollment in U.S. IDE Trial for iStent infinite™
    on October 10, 2019 at 11:00 am

    SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, today announced the completion of patient enrollment in its U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) trial for the iStent infinite™ Trabecular Micro-Bypass System. The iStent infinite is designed for use in a standalone […]

  • Glaukos Products to be Subject of Multiple Presentations at American Academy of Ophthalmology Annual Meeting
    on October 9, 2019 at 8:15 pm

    SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases, announced today that its products will be included in various presentations at the American Academy of Ophthalmology (AAO) annual meeting, which begins Saturday, October 12, 2019 at the Moscone Center in San Francisco, CA. Key presentations include: Saturday, October